Cambridge / London, UK, 28th September 2006: (‘BioProgress’ or the ‘Company’) (AIM: BPRG; NASDAQ: BPRG), the specialty pharma and drug delivery company, is pleased to announce its interim results for the six months ended 30 June 2006.
Cambridge / London, UK, 28th September 2006: (‘BioProgress’ or the ‘Company’) (AIM: BPRG; NASDAQ: BPRG), the specialty pharma and drug delivery company, is pleased to announce its interim results for the six months ended 30 June 2006.
